C
Cheng Ping Hu
Researcher at Central South University
Publications - 5
Citations - 1530
Cheng Ping Hu is an academic researcher from Central South University. The author has contributed to research in topics: Lung cancer & Afatinib. The author has an hindex of 5, co-authored 5 publications receiving 1216 citations.
Papers
More filters
Journal ArticleDOI
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
James Chih-Hsin Yang,Yi-Long Wu,Martin Schuler,Martin Sebastian,Sanjay Popat,Nobuyuki Yamamoto,Caicun Zhou,Cheng Ping Hu,Kenneth J. O'Byrne,Jifeng Feng,Shun Lu,Yunchao Huang,Sarayut Lucien Geater,Kye Young Lee,Chun-Ming Tsai,Vera Gorbunova,Vera Hirsh,Jaafar Bennouna,S. M. Orlov,Tony Mok,Michael Boyer,Wu Chou Su,Ki Hyeong Lee,Terufumi Kato,Dan Massey,Mehdi Shahidi,Victoria Zazulina,Lecia V. Sequist +27 more
TL;DR: In this article, the effect of Afatinib on overall survival of patients with EGFR mutation-positive lung adenocarcinoma through an analysis of data from two open-label, randomised, phase 3 trials was evaluated.
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
James Chih-Hsin Yang,Yi-Long Wu,Martin Schuler,Martin Sebastian,Sanjay Popat,Nobuyuki Yamamoto,Caicun Zhou,Cheng Ping Hu,Kenneth J. O'Byrne,Jifeng Feng,Shun Lu,Yunchao Huang,Sarayut Lucien Geater,Kye Young Lee,Chun-Ming Tsai,Vera Gorbunova,Vera Hirsh,Jaafar Bennouna,S. M. Orlov,Tony Mok,Michael Boyer,Wu Chou Su,Ki Hyeong Lee,Terufumi Kato,Dan Massey,Mehdi Shahidi,Victoria Zazulina,Lecia V. Sequist +27 more
TL;DR: Overall survival was significantly longer for patients with del19-positive tumours in the afatinib group than in the chemotherapy group in both trials: in LUX-Lung 3, median overall survival was 33.3 months (95% CI 26.8-41.5) and in Lux-lung 6, it was 31.4 months ( 95% CI 24.2-35.6), respectively.
Journal ArticleDOI
China Experts Consensus on the Diagnosis and Treatment of Advanced Stage Primary Lung Cancer (2016 Version)
Yuan Kai Shi,Yan Sun,Jinming Yu,Cui Min Ding,Ziping Wang,Chang Li Wang,Dong Wang,Cunde Wang,Zheng Wang,Mengzhao Wang,Xiu Yi Zhi,You Lu,Jifeng Feng,Yunpeng Liu,Xiaoqing Liu,Wei Liu,Gang Wu,Xiaomei Li,Kai Li,En Xiao Li,Wei Li,Gong Yan Chen,Zheng Tang Chen,Ping Yu,Ning Wu,Mi Lu Wu,Wenhua Xiao,Li Zhang,Yiping Zhang,Shu Cai Zhang,Shujun Yang,Xia Song,Dongmei Lin,Rong Cheng Luo,Li Shan,Caicun Zhou,Zong Mei Zhou,Qiong Zhao,Cheng Ping Hu,Yi Hu,Qisen Guo,Jian Hua Chang,Cheng Huang,Xuan Zeng,Bao Hui Han,Xiao Hong Han,Bo Jia,Ying Han,Yu Huang +48 more
Journal ArticleDOI
China experts consensus on the diagnosis and treatment of advanced stage primary lung cancer (2016 version).
Yuan Kai Shi,Yan Sun,Jinming Yu,Cui Min Ding,Ziping Wang,Chang Li Wang,Dong Wang,Cunde Wang,Zheng Wang,Mengzhao Wang,Xiu Yi Zhi,You Lu,Jifeng Feng,Yunpeng Liu,Xiaoqing Liu,Wei Liu,Gang Wu,Xiaomei Li,Kai Li,En Xiao Li,Wei Li,Gong Yan Chen,Zheng Tang Chen,Ping Yu,Ning Wu,Mi Lu Wu,Wenhua Xiao,Li Zhang,Yiping Zhang,Shu Cai Zhang,Shujun Yang,Xia Song,Dongmei Lin,Rong Cheng Luo,Li Shan,Caicun Zhou,Zong Mei Zhou,Qiong Zhao,Cheng Ping Hu,Yi Hu,Qisen Guo,Jian Hua Chang,Cheng Huang,Xuan Zeng,Bao Hui Han,Xiao Hong Han,Bo Jia,Ying Han,Yu Huang +48 more
TL;DR: The 307th Hospital of Chinese People’s Liberation Army General Hospital, Shanghai and the first Affiliated Hospital of Xi’an Jiaotong University are revealed.
Journal ArticleDOI
A consensus on immunotherapy from the 2017 Chinese Lung Cancer Summit expert panel.
Yi-Long Wu,Chang Li Wang,Mei Lin Liao,Zhong Zhen Guan,Chen Yan Gao,Shun Lu,Ming Fang Zhao,Jie Wang,Xiaoqing Liu,Jin Ji Yang,Jun Liang,Wei Min Mao,Bao Hui Han,X. Zhang,Yong Song,Ji Feng Feng,Sheng Lin Ma,Gang Wu,Cai Cun Zhou,Ke-Neng Chen,Ying Cheng,Yong He,Chun Chen,Qun Wang,Jizhen Lin,Bo Zhu,Yunpeng Liu,Yi Hu,Gui Bin Qiao,Qing Zhou,Qi Bin Song,Nan Wu,Lin Wu,Cheng Huang,Xiaolong Fu,Jian Ping Xiong,Jie Hu,Cheng Ping Hu,Jian Hua Chang,Qiong Zhao,Jun Zhao,Peng Hui Zhou,Zhi Yong Ma,Yuan Chen,He Long Zhang,Fan Yang,Jian Jun Wang,Yue Yin Pan,X.-N. Yang,Yun Fan,Zhe Liu,Wen Fan,Nong Yang,Yan Fang Guan,Hao Sun,Wen-Zhao Zhong +55 more
TL;DR: The notable clinical success of cancer immunotherapy using checkpoint blockade suggests that it is likely to form the foundation of curative therapy for many malignancies, but it does not achieve sustained clinical response in most patients and thus amounts of problems needed to be figured out.